Menopause Hormone Therapy (HRT) in Encinitas, CA

Bioidentical hormones in Encinitas: what it means

"Bioidentical" is a word compounding pharmacies often use in marketing, but what it describes is real: a hormone built like the body's own. Two hormones used in menopause care fit it exactly, estradiol and micronized progesterone. Neither has to be compounded: FDA-approved estradiol comes as pills, patches, gels, sprays, vaginal creams and rings, and progesterone as capsules.

Many products sold as "bioidentical hormones" or "BHRT" are compounded instead: mixed by a pharmacy for one prescription, often as a custom cream or a pellet. They are not FDA-approved, which means the FDA cannot assure their safety or effectiveness. The FDA also says it has no evidence that they are safe and effective, or more effective than approved hormone therapy. The National Academies, reviewing them for the FDA in 2020, called their wide use a public health concern.

23 OB-GYNs in the federal NPI registry give a primary practice address in Encinitas: 37.3 per 100,000 residents, above the US rate of 17.8 and above California's 16.9, and more per resident than 77% of the 924 cities VevaMD covers. Set against the city's 8,490 women aged 45 to 64, that is one OB-GYN for roughly every 370.

Within 25 miles of Encinitas there are 588 OB-GYNs for 2,284,975 residents (25.7 per 100,000), well above the national rate; 79 are in the city or within 10 miles. Whether or not you have an OB-GYN, you can ask a physician licensed in California about menopause hormone therapy online from Encinitas, with no waiting room.

For women in Encinitas, a physician licensed in California can prescribe estradiol (pill, patch, cream or vaginal) and progesterone when they fit your history. VevaMD does not offer pellets. The pharmacy that fills VevaMD prescriptions also compounds, so ask your physician whether yours is an FDA-approved product or compounded. Testosterone cream for women and Bi-Est are compounded and not FDA-approved.

A pellet clinic is a different model: it implants a hormone pellet under the skin during a visit, and compounded pellets are not FDA-approved. The Endocrine Society cites blood levels well above the expected range in women using compounded pellets. ACOG's guidance is to prefer FDA-approved menopause hormone therapy to compounded hormones.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11